Dr. Clive Patience
Advisors - Scientific Advisory Board
Advisors
Sernova Corp
Canada
Biography
One of the world's leading experts on biological safety of xenotransplantation, Dr. Patience is currently the Associate Director of Bioanalytical Quality Control at Biogen Idec. Inc. (NASDAQ: BIIB) in Cambridge Massachusetts. Dr. Patience obtained his Ph.D in virology from the University of London while working as a research scientist at the Institute of Cancer Research in London England. Much of his research focused on the biology of HIV, porcine endogenous retroviruses, and retroviral/adenoviral gene therapy vectors. In 2001 he joined Immerge Bio Therapeutics, a world leader in research to genetically modify pigs for organ transplants. While there he completed a 3 year study demonstrating the acceptable microbiological safety of pig to non-human primate transplants. In 2004 he joined Biogen Idec as a Senior Scientist before ascending to his current position. His research has been published in many peer reviewed journals including Nature Medicine, the Journal of Virology and the American Journal of Transplantation. He has also been an invited speaker to FDA safety committees.
Research Interest
Business and Management
